Income Tax Expense (Benefit) in USD of ReShape Lifesciences Inc. from 2014 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
ReShape Lifesciences Inc. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2014 to Q2 2025.
  • ReShape Lifesciences Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $8K, a 46.7% decline year-over-year.
  • ReShape Lifesciences Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2025 was $25K, a 60.3% decline year-over-year.
  • ReShape Lifesciences Inc. annual Income Tax Expense (Benefit) for 2024 was $39K, a 25% decline from 2023.
  • ReShape Lifesciences Inc. annual Income Tax Expense (Benefit) for 2023 was $52K.
  • ReShape Lifesciences Inc. annual Income Tax Expense (Benefit) for 2022 was -$380K, a 38.7% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

ReShape Lifesciences Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $25K $8K -$7K -46.7% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $32K $7K -$7K -50% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-20
Q4 2024 $39K $4K -$27K -87.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-04
Q3 2024 $66K $6K +$3K +100% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $63K $15K +$11K +275% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $52K $14K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-20
Q4 2023 $52K $31K +$87K Oct 1, 2023 Dec 31, 2023 10-K 2025-04-04
Q3 2023 -$35K $3K +$366K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$401K $4K -$5K -55.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$396K $14K -$16K -53.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$380K -$56K +$241K +81.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$621K -$363K -$333K -1110% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$288K $9K -$19K -67.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$269K $30K +$5K +20% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$274K -$297K -$205K -223% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$69K -$30K +$9K +23.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$78K $28K +$78K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-19
Q1 2021 -$156K $25K +$25K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$181K -$92K Oct 1, 2020 Dec 31, 2020 10-K 2022-04-08
Q3 2020 -$39K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$50K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12

ReShape Lifesciences Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $39K -$13K -25% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-04
2023 $52K +$432K Jan 1, 2023 Dec 31, 2023 10-K 2025-04-04
2022 -$380K -$106K -38.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$274K -$93K -51.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 -$181K -$195K -1393% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-08
2019 $14K +$3K +27.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $11K +$1K +10% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $10K +$8K +400% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-22
2016 $2K +$15K Jan 1, 2016 Dec 31, 2016 10-K 2018-03-05
2015 -$13K -$29K -181% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
2014 $16K Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.